P1140: COMBINATION ANTI-PD1 ANTIBODY AND RITUXIMAB FOLLOWED BY R-CHOP FOR NEWLY DIAGNOSED DLBCL IN ELDERLY PATIENTS: ANALYSIS OF THE PHASE II TREND TRIAL
Yan Gao,
Xue-Ping LI,
Xiao-Xiao Wang,
Bing Bai,
Xuan-Ye Zhang,
Su-Xia Lin,
Yan-Xia He,
LI-Qin Ping,
Cheng Huang,
Ji-Bin LI,
Jia-Ling Zhuang,
Hui-Qiang Huang
Affiliations
Yan Gao
1 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
Xue-Ping LI
2 Sun Yat-Sen University Cancer Center, Department of hematology, Guangzhou, China
Xiao-Xiao Wang
1 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
Bing Bai
1 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
Xuan-Ye Zhang
1 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
Su-Xia Lin
3 Sun Yat-Sen University Cancer Center, Department of pathology, Guangzhou, China
Yan-Xia He
4 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
LI-Qin Ping
4 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
Cheng Huang
4 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
Ji-Bin LI
5 Sun Yat-Sen University Cancer Center, Department of Clinical Research, Guangzhou, China
Jia-Ling Zhuang
4 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
Hui-Qiang Huang
1 Sun Yat-Sen University Cancer Center, Department of Medical Oncology, Guangzhou, China
